Creo Medical has announced the successful treatment of its first patients in the US. Following training over the weekend, two US surgeons each performed a procedure using Creo's Speedboat device, one in the upper and one in the lower gastrointestinal tract. This is clearly a significant milestone for Creo Medical given the size and growth potential of the US market. The US treatments follow previous announcements of procedures performed in Europe, South Africa and the UK. We maintain our Buy rec ....
16 Jan 2019
Cenkos: Creo Medical Group Plc - Significant treatment milestone
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Cenkos: Creo Medical Group Plc - Significant treatment milestone
Creo Medical Group Plc (CREO:LON) | 34.2 0 0.0% | Mkt Cap: 123.8m
- Published:
16 Jan 2019 -
Author:
Chris Donnellan -
Pages:
5
Creo Medical has announced the successful treatment of its first patients in the US. Following training over the weekend, two US surgeons each performed a procedure using Creo's Speedboat device, one in the upper and one in the lower gastrointestinal tract. This is clearly a significant milestone for Creo Medical given the size and growth potential of the US market. The US treatments follow previous announcements of procedures performed in Europe, South Africa and the UK. We maintain our Buy rec ....